Molina Healthcare (MOH) will be removed from the S&P 500 and added to the S&P SmallCap 600 ahead of March 23, 2026. That mechanically-driven rebalancing, plus an upcoming Q1 earnings release on April 22 and conference call on April 23, creates a window of elevated volume and short-term price volatility driven by index flows rather than fundamentals.

Molina Healthcare (MOH) fell out of the S&P 500 after a Q4 2025 earnings shock and steep guidance cut. The index reclassification, effective March 23, 2026, creates forced selling and short-term volatility while the company works to control medical-cost trends and rebuild margins.

Molina Healthcare’s removal from the S&P 500 and persistent cost pressures—driven by high medical loss ratios and muted Medicare Advantage rate updates—are creating short-term downside risk through forced index selling and margin compression.

Recent federal and state actions — a tightened CMS oversight bulletin, Minnesota’s proposal to eliminate MCOs, and a near‑flat 2027 Medicare Advantage rate notice — have elevated near‑term operational and margin risks for Molina Healthcare (MOH). This article explains the concrete regulatory moves from the past week, quantifies how they intersect with Molina’s Medicaid and MA exposure, and highlights near‑term catalysts investors should monitor.

Molina Healthcare (MOH) has seen fresh headwinds this week after Capital World Investors trimmed its stake and a shareholder-law firm launched an inquiry into company leadership. Analyst downgrades and persistent managed-care margin pressure have amplified volatility for the S&P 500 insurer. This article summarizes the events, market reactions, and near-term implications for investors.

Molina Healthcare reported a surprise Q4 loss and drastically lowered guidance, triggering a steep share decline and strategic withdrawal from Medicare Advantage Part D. This article summarizes the confirmed financial hits, market reaction, operational pivots, and investor watchpoints.